Basecamp Research funding news – London-based Basecamp Research Secures $60 Million in Series B Round Funding

Basecamp Research partners with biopharma companies and academic research institutions to create innovative protein sequences and biological systems, revolutionizing therapeutic research and development.

Read also - Harmonic Security funding news – London-based Harmonic Security Raises $17.5Million in Series A Round Funding

Dr. Glen Gowers, co-founder and CEO of Basecamp Research said, “We are pushing past AI’s limits in biological design by doubling down on solving the fundamental data gap that the entire biotech industry faces, Basecamp Research is using its technology to generate new and deeper insights, going beyond known biology and each day expand what we can offer to our partners in the biopharma ecosystem.”

In collaboration with Dr. Liu’s laboratory, Basecamp Research is at the forefront of developing novel fusion proteins and large molecules for the future of genetic medicines.

Singular led Basecamp Research’s funding, with additional investments from S32, redalpine, André Hoffmann, Feike Sijbesma, and Paul Polman. Noteworthy returning investors include True Ventures and Hummingbird Ventures in the recent Series B round.

The company's strategic partnership with Dr. David R Liu at the Broad Institute of MIT and Harvard signifies a significant step forward. Dr. Liu, a Howard Hughes Medical Institute Investigator, and Core Member at the Broad Institute bring invaluable expertise to this collaboration.

Raffi Kamber, General Partner at Singular, said: "The team at Basecamp Research is building powerful AI models that truly understand the breadth and complexity of biology. Their knowledge graph offers a step change in the performance of AI-based design and a fundamental shift in how life science teams innovate. We’re thrilled to support a visionary company and team poised to reshape an entire industry."

Basecamp Research co-founder Dr. Oliver Vince added: “We’ve used AI to solve a wide range of challenging bioscience problems, and we look forward to continuing to work with partners on breakthrough projects. We are thrilled by this momentum and look forward to continuing to go beyond the limits of today’s known biology.”

About Basecamp Research

Basecamp Research leads the way in mapping biodiversity for AI-based design of biological systems. Their innovative approach involves matching and refining novel proteins tailored for industrial, therapeutic, or diagnostic applications. With BaseGraph™, a cutting-edge AI design platform fueled by the world's first high-resolution map of global genetic biodiversity, they strive to revolutionize the field.